The mRNA vaccines made by Moderna as well as the partnership between Pfizer-BioNTech are also cleared for use by this age group, the Medici...

Novavax's protein-based vaccine was approved for emergency use by the US Food and Drug Administration (USFDA) last month in India.

SII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax. Poonawalla further...

The USFDA approval makes SII - the first Indian vaccine maker to export vaccines to the US market, a testimony to the company's abilities t...

He was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for restrict...

Novavax's two-dose, protein-based vaccine was authorized for use this week by European Union regulators and the World Health Organization.

The Novavax shot joins those from Pfizer-BioNTech, Moderna, Johnson & Johnson and AstraZeneca in the EU's vaccine armory.

Pune-based Serum Institute of India (SII) had applied to the Indian drug regulator in August for EUA for the launch of Covovax. However, it...

The large Novavax trials conducted on 29,960 persons in the US and Mexico have delivered results that equal the Pfizer and Moderna jabs and...

Serum Institute, which has signed up to manufacture upto 1 billion doses of Novavax's vaccine, is expected to file for approval in India in...

The statement from SII comes at a time when the Modi government is facing criticism by opposition parties on why did it allow SII to export...

In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation ...

Novavax said its NVX-CoV2373 demonstrated a 90% efficacy in phase 3 trials in the UK, taking it closer to approval by the UK health authori...

Novavax's UK trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for use in Britain, the European Union and ...

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses ...

Cadila said it has recieved regulatory approval for conducting rabies vaccine toxicology studies in India and clinical study of influenze v...